Anti-Leukemic Activity of Luveltamab Tazevibulin (LT, STRO-002), a Novel Folate Receptor-α (Fr-Α)-targeting Antibody Drug Conjugate (ADC) in Relapsed/Refractory CBF2AT3::GLIS2 AMLRobin Williams,Lane H. Miller,Stephanie Massaro,Elizabeth Krieger,Melinda Pauly, C. Michael Nelson,Rebecca H. Johnson, Jennifer Welch,Deepa Bhojwani,Babak Moghimi,Philip Neff,Terzah M. Horton,Hamayun Imran,Raul C. Ribeiro,Terri Guinipero,Matthew A. Kutny, Felipe Bautista,Amy J. Wagoner Johnson,Karen Lewing,Alan S. Gamis,Julienne Brackett,David McCall,Teena Bhatla,Maria Luisa Sulis, Amy Tellinghuisen,Jill C. Beck,Soheil MeshinchiBlood（2023）引用 0|浏览4AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
